Keep Up With McLean!
Receive the latest news in your inbox each month.
Jason Hassenstab, PhD, is the Cognition Core director for the Dominantly-Inherited Alzheimer Network-Trials Unit (DIAN-TU) and the DIAN observational study. He is currently an assistant professor of neurology and of psychological and brain sciences at Washington University in St. Louis, and is the director of neuropsychology for the Knight Alzheimer’s Disease Research Center. His research is focused on assessment approaches for detection of cognitive changes in the earliest stages of Alzheimer’s disease and their relationship to fluid biomarkers and neuroimaging indicators of Alzheimer’s disease pathology. He is also developing remote cognitive assessment paradigms using ecological momentary assessment and measurement burst designs for use in cohort studies and clinical trials. He joined the faculty at Washington University in St. Louis in 2010.
This talk was part of the 2017 Technology in Psychiatry Summit, sponsored by the McLean Institute for Technology in Psychiatry on November 6-7, 2017, at the JB Martin Conference Center, Harvard Medical School. Part of panel: Digital Technology in Practice: Applications in Geriatric Health.
The implications of a rapidly growing population of older adults on healthcare costs, housing, and public policy are well-recognized. The world of aging is at the forefront of innovation in the use of technologies to support independent living, maximized functioning, and improvements in cost, efficiency, and personalization of clinical care. This session focuses on exploring how the worlds of aging, technology, and mental health can intersect and what might be the most fruitful spaces to explore within this domain.future to lead us to a better understanding of mental health, the brain, and behavior.
Please visit mclean.org/itp to learn more about the McLean Institute for Technology in Psychiatry.
Back to top